Skip to main content

Alphabet Inc.'s Form 4 filing

Prime Medicine, Inc. (PRME) · filed Jun 2, 2023

Accession no.
0001209191-23-033697
Filed
Jun 2, 2023, 4:17 PM ET
Trade date
May 31-Jun 1, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $876.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Alphabet Inc.CIK 000165204410% Owner
GV 2019 GP, L.L.C.CIK 000184503810% Owner
GV 2019 GP, L.P.CIK 000184503910% Owner
GV 2019, L.P.CIK 000184504110% Owner
GV 2021, L.P.CIK 000186120210% Owner
GV 2021 GP, L.L.C.CIK 000186120610% Owner
GV 2021 GP, L.P.CIK 000186121610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 31, 2023Common StockJOtherDisposed−16,633$0.00$010,436,052Indirect
May 31, 2023Common StockSSaleDisposed−16,633$13.65−$227,003.860Indirect
Jun 1, 2023Common StockJOtherDisposed−45,223$0.00$010,390,829Indirect
Jun 1, 2023Common StockSSaleDisposed−44,752$14.35−$642,244.9471Indirect
Jun 1, 2023Common StockSSaleDisposed−471$14.75−$6,948.850Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)